29.09.2022 Drägerwerk AG & Co. KGaA  DE0005550602

EQS-News: Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission


 

EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Miscellaneous
Drägerwerk AG & Co. KGaA: Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission

29.09.2022 / 14:26 CET/CEST
The issuer is solely responsible for the content of this announcement.


Notification pursuant to Art. 5 (1) of the Regulation (EU) No 596/2014 and Art. 2 (1) of the Delegated Regulation (EU) 2016/1052 of the Commission

On September 26, 2022, the Executive Board of Drägerwerk Verwaltungs AG resolved an employee participation program for Drägerwerk AG & Co. KGaA (“Dräger”). For this purpose, Dräger will buy back some of its own preferred shares on the stock exchange in the period from October 5 to probably November 16, 2022. The corresponding shares will not be retired, but will remain in the share accounts of the participating employees during the two-year lock-up period.

Within the last year's employee participation program, Dräger bought back just under 90,000 of a theoretical 646,320 shares. In the current year, the buyback volume could be higher as, for the first time, the Executive Board is entitled to invest part of its variable remuneration in the program. Theoretically, up to 706,520 shares could be rebought. However, this would only occur if all eligible employees and the Executive Board participate fully in the program.

The share buyback principally complies with rules and regulations set forth in Sec. 71 (1) Sentence 1 No 2 AktG (Aktiengesetz − German Stock Corporation Act). The buyback of preferred shares held by persons not employed by the Company or any associated company, neither at the present time nor in the past, will take place in accordance with the authorization issued by the Company’s annual shareholders’ meeting dated 7 May 2021, which permits the buyback of up to 10 percent of capital stock held in the form of own shares.

A bank will be tasked with the buyback. The bank will make its decisions concerning the time of purchase of the preferred shares independently of Dräger and free of its influence. The right of Dräger to terminate its contract with the bank early and assign the task to a different bank remains unaffected.

In both cases, the buyback complies with the so-called safe-harbor rules set forth in Art. 5 of the Regulation (EU) No 596/2014 in connection with the Delegated Regulation (EU) 2016/1052 of the Commission.

The buyback will be made on the stock exchange. The purchase price will comply with the requirements set forth in the safe-harbor rules. In addition, the purchase price per preferred share (excluding acquisition charges) of those preferred shares to be acquired on the basis of the authorization issued by the annual shareholders’ meeting may not exceed or fall below the price of the preferred shares in the opening auction in XETRA trading on the Frankfurt Stock Exchange on the corresponding trading day in question by more than 10 percent.

The share buyback may be suspended and resumed at any time in accordance with the relevant legal guidelines.

The transactions will be announced by the end of the seventh trading day after their conclusion at the latest in a method in accordance with the requirements set forth in Art. 2 (2) of the Delegated Regulation (EU) 2016/1052 of the Commission.

Dräger will report on the course of the buyback program in accordance with the legal provisions on the Company’s website (www.draeger.com) in the Investor Relations section.

Lübeck, Germany, September 29, 2022

Executive Board
Drägerwerk Verwaltungs AG, acting as the general partner of
Drägerwerk AG & Co. KGaA

Moislinger Allee 53–55
23558 Lübeck, Germany
www.draeger.com


Disclaimer
This release contains statements on the future development of Dräger Group. These forward-looking statements are based on the current expectations, presumptions, and forecasts of the Executive Board as well as the information available to it to date and have been prepared to the best of its knowledge and belief. No guarantee or liability for the occurrence of the future developments and results specified can be assumed in respect of such forward-looking statements. Rather, the future developments and results are dependent on a number of factors. They entail risks and uncertainties beyond the Company’s control and are based on assumptions which could prove to be incorrect. Notwithstanding any legal requirements to adjust forecasts, Dräger does not assume any obligation to update the forward-looking statements contained in this report. You will find all important financial dates on our Company website at www.draeger.com under Investors/Financial Calendar.



29.09.2022 CET/CEST Dissemination of a Corporate News, transmitted by EQS - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: Drägerwerk AG & Co. KGaA
Moislinger Allee 53-55
23558 Lübeck
Germany
Phone: +49 (0)451 882-0
Fax: +49 (0)451 882-2080
E-mail: [email protected]
Internet: www.draeger.com
ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 071 9
WKN: 555060, 555063 Vorzüge, 555071 Genussschein D
Indices: SDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Stuttgart, Tradegate Exchange
EQS News ID: 1453261

 
End of News EQS News Service

1453261  29.09.2022 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1453261&application_name=news&site_id=boersengefluester_html


Die wichtigsten Finanzdaten auf einen Blick
  2017 2018 2019 2020 2021 2022 2023e
Umsatzerlöse1 2.572,26 2.595,01 2.780,82 3.406,78 3.328,42 3.045,23 3.375,50
EBITDA1,2 240,00 147,91 193,71 521,07 421,00 55,80 315,00
EBITDA-Marge3 9,33 5,70 6,97 15,30 12,65 1,83
EBIT1,4 155,74 62,65 66,58 396,60 271,68 -88,61 166,43
EBIT-Marge5 6,05 2,41 2,39 11,64 8,16 -2,91 4,93
Jahresüberschuss1 98,50 34,90 33,79 249,89 154,27 -63,64 111,99
Netto-Marge6 3,83 1,34 1,22 7,34 4,64 -2,09 3,32
Cashflow1,7 143,34 4,09 164,42 459,98 384,89 -144,23 189,68
Ergebnis je Aktie8 4,12 1,42 1,38 10,19 7,13 -3,41 5,86
Dividende8 0,40 0,13 0,13 0,13 0,13 0,13 0,13
Quelle: boersengefluester.de und Firmenangaben

  Geschäftsbericht 2023 - Kostenfrei herunterladen.  
1 in Mio. Euro; 2 EBITDA = Ergebnis vor Zinsen, Steuern und Abschreibungen; 3 EBITDA in Relation zum Umsatz; 4 EBIT = Ergebnis vor Zinsen und Steuern; 5 EBIT in Relation zum Umsatz; 6 Jahresüberschuss (-fehlbetrag) in Relation zum Umsatz; 7 Cashflow aus der gewöhnlichen Geschäftstätigkeit; 8 in Euro; Quelle: boersengefluester.de

Wirtschaftsprüfer: -

INVESTOR-INFORMATIONEN
©boersengefluester.de
Drägerwerk ST
WKN Kurs in € Einschätzung Börsenwert in Mio. €
555060 43,900 Kaufen 882,90
KGV 2025e KGV 10Y-Ø BGFL-Ratio Shiller-KGV
8,13 17,22 0,47 12,06
KBV KCV KUV EV/EBITDA
0,60 4,34 0,26 3,51
Dividende '22 in € Dividende '23e in € Div.-Rendite '23e
in %
Hauptversammlung
0,13 1,74 3,96 08.05.2024
Q1-Zahlen Q2-Zahlen Q3-Zahlen Bilanz-PK
25.04.2024 25.07.2024 29.10.2024 07.03.2024
Abstand 60Tage-Linie Abstand 200Tage-Linie Performance YtD Performance 52 Wochen
1,26% 4,08% -1,79% 9,75%
    
Weitere Ad-hoc und Unternehmensrelevante Mitteilungen zu Drägerwerk AG & Co. KGaA  ISIN: DE0005550602 können Sie bei EQS abrufen


Medtech , 555060 , DRW8 , XETR:DRW8